Delivery Order SPE2DR25D9331-SPE2DR26FQPZ2
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Altafluor Benox 0.25%-0.4% drops in a 5ML quantity. This firm fixed-price delivery order, valued at $1,014.24, was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at the contractor's Park Ridge facility. The award carries no set-aside...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,014.00 to DMS Pharmaceutical Group Inc. for Altafluor Benox 0.25%-0.4% ophthalmic drops (5mL) with an ultimate completion date of November 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,014.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Altafluor Benox 0.25%-0.4% eye drops in 5 milliliter vials, with a period of performance through November 1, 2024. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $1,680 firm fixed-price delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Altafluor Benox 0.25%-0.4% drops in 5ml units. The award carries an ultimate completion date of September 29, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.40 contract is for the delivery of Altafluor Benox 0.25%-0.4% Drops 5ml, a specialized pharmaceutical product, with a completion date of March 17, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,021.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 17, 2025, represents one of multiple orders executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,358 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 1, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The...
- The Defense Logistics Agency awarded a $1,988.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued December 12, 2025, represents one of numerous purchases under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract was established...
- The Defense Logistics Agency issued a $7,629.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
- The Defense Logistics Agency awarded a $25,646.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, represents one of numerous pharmaceutical supply orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA. The contract utilizes no set-aside designation, demonstrating the contractor's competitive capability...
- SPE2DR25D9331Indefinite Delivery Contract
- SPE2DR25D9331-SPE2DR26FQPZ2Delivery Order
The Defense Logistics Agency awarded a $1,014 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Altafluor Benox 0.25%-0.4% drops in 5mL quantities. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and was awarded on January 2, 2026. This award carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. The place of performance is located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion vehicle established on November 13, 2025. The PPV-G GEN V contract positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion acquisition strategy, authorizing DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. The company's established performance on numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for the federal military medical system through 2036.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/1/26 |